Korsana Biosciences, Inc. (KRSA) vs Neuronetics, Inc. (STIM)
A side-by-side comparison of Korsana Biosciences, Inc. and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KRSA
Korsana Biosciences, Inc.
$31.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
STIM
Neuronetics, Inc.
$2.22HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — KRSA vs STIM
growth of $100 · dividends reinvested · last 8yKRSA -98.2% (-39.7%/yr)STIM -86.4% (-22.1%/yr)STIM compounded faster over this window
Log scale — wide-divergence pair
KRSA STIM
KRSA vs STIM: by the numbers
- •STIM is the larger company ($154M vs $149M market cap).
- •Both run net losses; STIM's is the smaller (-19.62% vs -353.00% net margin).
- •STIM grew revenue faster over the past five years (23.26% vs -11.98% CAGR).
Metrics side by side
Valuation
| Metric | KRSA | STIM |
|---|---|---|
| P/S ratio | 78.28 | 0.99 |
| P/B ratio | 29.24 | 8.65 |
Profitability
| Metric | KRSA | STIM |
|---|---|---|
| Gross margin | 100.00% | 49.12% |
| Operating margin | -239.78% | -14.74% |
| Net margin | -353.00% | -19.62% |
| ROE | -131.85% | -170.49% |
| ROIC | -134.15% | -22.15% |
Growth (annualized)
| Metric | KRSA | STIM |
|---|---|---|
| Revenue CAGR (5Y) | -11.98% | 23.26% |
| Total return CAGR (5Y) | -40.41% | -19.46% |
Frequently asked
- Which has grown faster, KRSA or STIM?
- Over the past five years, STIM grew revenue faster — KRSA at a -11.98% CAGR versus STIM at 23.26%.
- How have KRSA and STIM total returns compared?
- Over the past 5 years, KRSA delivered -40.41% and STIM delivered -19.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Korsana Biosciences ROENeuronetics ROEKorsana Biosciences operating marginNeuronetics operating marginKorsana Biosciences revenue growthNeuronetics revenue growthKorsana Biosciences free cash flowNeuronetics free cash flow
Korsana Biosciences & Neuronetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.